<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04512456</url>
  </required_header>
  <id_info>
    <org_study_id>FAPERJ E-26/010.100935/2018</org_study_id>
    <nct_id>NCT04512456</nct_id>
  </id_info>
  <brief_title>Cardiovascular Responses to Exercise in People Living With HIV/AIDS: Effects of Exercise Training</brief_title>
  <official_title>Autonomic and Hemodynamic Responses to Muscular Ergoreflex Activation in People Living With HIV/AIDS: Effects of Exercise Training.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Cardiologia de Laranjeiras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rio de Janeiro State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Nacional de Cardiologia de Laranjeiras</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: People living with HIV (PLHIV) present impaired muscle metaboreflex, which may&#xD;
      lead to exercise intolerance and increased cardiovascular risk. This study will aim to&#xD;
      investigate the effects of exercise training on autonomic and hemodynamic responses to muscle&#xD;
      ergoreflex activation in PLHIV. Methods: This is a randomized controlled clinical trial, in&#xD;
      which PLHIV without regular physical exercise will be randomly assigned at a ratio of 1:1&#xD;
      into an intervention or a control group. The intervention group will perform an exercise&#xD;
      training program (aerobic, strength and flexibility exercises) for 12 weeks (60-min session&#xD;
      performed 3 times/wk with moderate intensity) and the control group will remain inactive. A&#xD;
      reference group composed of inactive HIV-uninfected group will be included. The primary&#xD;
      outcomes will be blood pressure and autonomic markers in response to the Stroop Color-Word&#xD;
      Test and the activation of muscle ergoreflex, by means of the post-exercise circulatory&#xD;
      arrest (PECA), being the latter performed with and without the application of a&#xD;
      capsaicin-based analgesic balm in the exercised limb. Secondary outcomes will be peripheral&#xD;
      vascular resistance, cardiac output, heart rate and blood lactate. The active and inactive&#xD;
      PLHIV groups will be evaluated at baseline and after the intervention, while the reference&#xD;
      group only at baseline.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HIV-infection is associated to a reduced maximal cardiac output and blunted pressor reflex&#xD;
      response to static handgrip exercise, which are suggestive of impaired ergoreflex activation.&#xD;
      An abnormal ergoreflex activation may lead to exercise intolerance and increases in&#xD;
      cardiovascular risk. Despite the importance of therapeutic strategies in reducing the&#xD;
      cardiovascular risk among patients living with HIV, exercise-related effects on ergoreflex&#xD;
      sensitivity in these population have not been previously investigated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>HIV+active group will perform exercise training, while HIV+inactive and HIV- groups will not undergo intervention.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Blood Pressure at 3 months</measure>
    <time_frame>Baseline and 3 months of follow-up</time_frame>
    <description>Blood pressure will be assessed by photoplethysmography.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Heart Rate at 3 months</measure>
    <time_frame>Baseline and 3 months of follow-up</time_frame>
    <description>Heart rate will be evaluated beat-to-beat by means of a heart rate monitor.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>Active HIV-infected patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inactive HIV-infected patients</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <description>Exercise training performed during 12 weeks, 3 sessions per week of 60 minutes of strength and aerobic exercises.</description>
    <arm_group_label>Active HIV-infected patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for people living with HIV:&#xD;
&#xD;
          -  diagnosis of HIv infection for at least 5 years;&#xD;
&#xD;
          -  use of combined antiretroviral therapy for at least 3 years;&#xD;
&#xD;
          -  asymptomatic and free from opportunistic diseases at enrollment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  regular physical exercise;&#xD;
&#xD;
          -  malnutrition;&#xD;
&#xD;
          -  presence of coronary artery disease, ischemic diseases, pulmonary disease, diabetes,&#xD;
             Chagas disease, tuberculosis, heart failure, hypertension;&#xD;
&#xD;
          -  using pacemakers and/or antidepressant, antiarrhythmic or antihypertensive medication,&#xD;
             especially beta-blockers.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julana P Borges, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rio de Janeiro State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juliana P Borges, Dr.</last_name>
    <phone>+552123340775</phone>
    <email>julipborges@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriel S Gama</last_name>
    <phone>+552123340775</phone>
    <email>profgabrielgama@gmail.com</email>
  </overall_contact_backup>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 7, 2020</study_first_submitted>
  <study_first_submitted_qc>August 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2020</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rio de Janeiro State University</investigator_affiliation>
    <investigator_full_name>Juliana Pereira Borges</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

